First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (TRAXV) — Financial Flexibility Index
First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (TRAXV) has a Financial Flexibility Index of -2.49x as of December 2024. Free cash flow of $-125.45 Million (operating CF $-125.81 Million minus capex $358.00K) represents -2% of total liabilities ($50.30 Million). Also explore net asset growth rate of First Tracks Biotherapeutics, Inc. Ordin to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued Financial Flexibility Index (2023–2024)
Historical Financial Flexibility Index trend for First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued across 2 annual periods. Check First Tracks Biotherapeutics, Inc. Ordin (TRAXV) strategic investment index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (2023–2024)
Year-by-year free cash flow to debt coverage for First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued. For the full company profile including market capitalisation, see how much is First Tracks Biotherapeutics, Inc. Ordin worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.49x | $-125.45 Million | $-125.81 Million | $50.30 Million | ▲ +7.3% |
| 2023 | -2.69x | $-92.20 Million | $-93.00 Million | $34.26 Million | — |